Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic ...

The Food and Drug Administration (FDA) has granted Fast Track designation to troculeucel, an autologous natural killer (NK) cell therapy, for the treatment of moderate Alzheimer disease (AD).

This article originally appeared in Research Colorado.Research at the University of Denver is showing promise for the ...

A 75-year-old man defies Alzheimer's genetics baffling researchers unraveling potential breakthroughs in prevention and treatment.